CHEK's logo.
Ticker Symbol: CHEK

Check-Cap Ltd

$0.91 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Country: Israel Currency: USD Asset Type: Common Stock CIK:0001610590

Company Profile

Check-Cap is a clinical stage medical diagnostics company aiming to redefine colorectal cancer (CRC) preventionthrough the introduction of C-Scan®, thefirst and onlypatient-friendly preparation-freescreening test to detect polypsbeforethey may transform into cancer. The Company'sdisruptivecapsule-basedscreening technology aims to significantly increasescreening adherenceworldwide and help millions of people tostay healthy through preventive CRC screening. C-Scan uses an ultra-low dose X-ray capsule, an integrated positioning, control and recording system, as well as proprietary software to generate a 3D map of the inner lining of the colon. C-Scan is non-invasive and requires no preparation or sedation, allowing the patients to continue their daily routine with no interruption as the capsule is propelled through the gastrointestinal tract by natural motility.

Sector: Manufacturing
Industry: Irradiation Apparatus Manufacturing
Standard Industrial Classification Code (SIC code): 3844
Address: 29 Abba Hushi Ave.
CEO: Alex Ovadia
Tags:
  • Health Technology
  • Medical Specialties
  • Manufacturing
  • Irradiation Apparatus Manufacturing

Pricing

Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $3.23
Change: $0.01 ( 0.31%)
Days Range: $3.15 - $3.34
Beta: 0.31
52wk. High: $5.90
52wk. Low: $0.22
Ytd. Change 46.67%
50 Day Moving Average: $3.59
200 Day Moving Average: $2.62
Shares Outstanding: 5846989

Valuation

Market Cap: 1.9B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A